EGFR and non-small cell lung carcinoma: Epidermal growth factor receptor (EGFR) genotyping is a routine test to assess non‐small‐cell lung cancer (NSCLC) patients’ eligibility to receive EGFR tyrosine kinase inhibitor (TKI) therapy.